Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and EGCG: the role of p53-dependent inhibition of nuclear factor-kappaB

Ítems similars

• Unraveling Regulatory Programs for NF-kappaB, p53 and MicroRNAs in Head and Neck Squamous Cell Carcinoma
  per: Yan, Bin, et al.
  Publicat: (2013)
• Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma.
  per: Bin Yan, et al.
  Publicat: (2013-01-01)
• Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer
  per: Li, Rui, et al.
  Publicat: (2013)
• Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth in vivo in head and neck cancer models
  per: Amin, A.R.M. Ruhul, et al.
  Publicat: (2021)
• Synergistic inhibition of head and neck tumor growth by green tea (−)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor
  per: Zhang, Xin, et al.
  Publicat: (2008)